⊗This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

⊗This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

Adamax 5mg

SKU: PEP0005
In Stock
Adamax is a synthetic nootropic peptide of the melanocortin/ACTH family, structurally derived from the heptapeptide Semax (ACTH 4-7 + Pro-Gly-Pro) with an adamantane modification that increases enzymatic stability, lipophilicity, and blood-brain barrier penetration. Research on the Semax scaffold demonstrates upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the hippocampus, enhanced learning and memory retention, and marked neuroprotection in cerebral ischemia models. A single dose of Semax raised hippocampal BDNF protein 1.4-fold and TrkB phosphorylation 1.6-fold, supporting neuronal survival, synaptic plasticity, and cognitive resilience under stress.
$55.00

What is Adamax?

What is Adamax?

Adamax is a research compound with well-documented chemical properties. This compound has the molecular formula C28H30F3N7O3 and a molecular weight of 569.6 g/mol.

Chemical Identity

The compound is characterized by its unique molecular structure and specific chemical properties that make it valuable for research applications.
Systematic IUPAC Name: N-[6-[4-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyrimidin-4-yl]cyclopropanecarboxamide

Research Applications

Adamax is widely used in scientific research and laboratory studies. Researchers utilize this compound to investigate various biochemical pathways, mechanisms of action, and potential applications in different fields of study.

Purity & Quality

Our Adamax is provided at research-grade purity, suitable for laboratory applications and experimental protocols. Each batch undergoes quality control testing to ensure consistency and reliability for your research needs. Important: This product is intended for research purposes only and is not for human or veterinary use. It is sold for laboratory and scientific investigation only.

Adamax Structure

 

Chemical Structure

2D Structure

Adamax 2D Structure

3D Structure

Adamax 3D Structure

Chemical Properties

CAS Number 1421227-52-2
Molecular Formula C28H30F3N7O3
Molecular Weight 569.6 g/mol
IUPAC Name
N-[6-[4-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyrimidin-4-yl]cyclopropanecarboxamide
InChIKey KIKOYRNAERIVSJ-UHFFFAOYSA-N

Adamax Research

 

Scientific Research

The following peer-reviewed research articles have been published about Adamax:

1. Enhancing accuracy in brain stroke detection: Multi-layer perceptron with Adadelta, RMSProp and AdaMax optimizers.

Uppal M et al.. Enhancing accuracy in brain stroke detection: Multi-layer perceptron with Adadelta, RMSProp and AdaMax optimizers. Front Bioeng Biotechnol. 2023;11:1257591. PMID: 37823024

2. Effective skin cancer classification by modified and optimized inception-ResNet-V2 model.

Umapathi K et al.. Effective skin cancer classification by modified and optimized inception-ResNet-V2 model. Sci Rep. 2025;15(1):41150. PMID: 41266780

3. Artificial Intelligence-based fine-tuning model for fall activity recognition in disabled persons within an IoT environment.

Alzahrani A et al.. Artificial Intelligence-based fine-tuning model for fall activity recognition in disabled persons within an IoT environment. Sci Rep. 2025;16(1):694. PMID: 41326571

4. Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer.

Lee TF et al.. Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer. Radiat Oncol. 2024;19(1):5. PMID: 38195582

5. An intelligent LinkNet-34 model with EfficientNetB7 encoder for semantic segmentation of brain tumor.

Sulaiman A et al.. An intelligent LinkNet-34 model with EfficientNetB7 encoder for semantic segmentation of brain tumor. Sci Rep. 2024;14(1):1345. PMID: 38228639

6. A robust stacked ensemble strategy with multi-optimizer CNN models for skin cancer classification.

Panwar A et al.. A robust stacked ensemble strategy with multi-optimizer CNN models for skin cancer classification. Sci Rep. 2026; PMID: 42151239

7. Deep learning model for early acute lymphoblastic leukemia detection using microscopic images.

Anand V et al.. Deep learning model for early acute lymphoblastic leukemia detection using microscopic images. Sci Rep. 2025;15(1):29147. PMID: 40783578

8. Diagnosis of Autism Spectrum Disorders in Young Children Based on Resting-State Functional Magnetic Resonance Imaging Data Using Convolutional Neural Networks.

Aghdam MA, Sharifi A, Pedram MM. Diagnosis of Autism Spectrum Disorders in Young Children Based on Resting-State Functional Magnetic Resonance Imaging Data Using Convolutional Neural Networks. J Digit Imaging. 2019;32(6):899-918. PMID: 30963340

9. Augmented Multimodal Fusion for Optimized Brain Tumor Detection: Evaluation and Comparative Analysis.

Tuteja P et al.. Augmented Multimodal Fusion for Optimized Brain Tumor Detection: Evaluation and Comparative Analysis. J Vis Exp. 2025;(220) PMID: 40587439

10. Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilar.

Guerrieri D et al.. Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilar. Bioanalysis. 2024;16(1):33-48. PMID: 38031738
Disclaimer: The research articles listed above are for informational purposes only. This product is intended for research use only and not for human or veterinary use.
⊗PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
Shopping cart